Wird geladen...
Changing strategies for target therapy in gastric cancer
In spite of a worldwide decrease in the incidence of gastric cancer, this malignancy still remains one of the leading causes of cancer mortality. Great efforts have been made to improve treatment outcomes in patients with metastatic gastric cancer, and the introduction of trastuzumab has greatly imp...
Gespeichert in:
| Veröffentlicht in: | World J Gastroenterol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4716029/ https://ncbi.nlm.nih.gov/pubmed/26811656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i3.1179 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|